MedTrace Logo

Effect of Injectable Platelet-Rich Fibrin (i-PRF) in Initial Treatment of Chronic Periodontitis

NCT04178590 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2020-07-13

Study results available
· View outcomes & findings →

Summary

Current treatments of periodontitis have limited efficacy since they fail to suppress microorganisms satisfactorily over time. The aim of present study was to investigate whether there are differences between initial treatment of chronic periodontitis (SRP) and SRP in conjunction with injectable platelet-rich fibrin (i-PRF) application.

Conditions

  • Periodontitis

Interventions

DRUG

SRP + Injectable Platelet-Rich Fibrin

Injectable Platelet-Rich Fibrin application as adjunct to scaling and root planing

DRUG

SRP + placebo

Saline application during scaling and root planing

Sponsors & Collaborators

  • University of Belgrade

    lead OTHER

Principal Investigators

  • Mila Vuckovic, Dr. · Assistant Lecturer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-02
Primary Completion
2020-06-29
Completion
2020-07-09

Countries

  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04178590 on ClinicalTrials.gov